[Reactivity of five different antibodies with benign and malignant melanocytic lesions]

Vanda Plótár1, Zoltán Szentirmay, Zsolt Orosz

  • 1Országos Onkológiai Intézet, Daganatpatológiai Osztály, 1122 Budapest Ráth Gy. u. 7-9. plotar.vanda@oncol.hu

Magyar Onkologia
|December 11, 2008
PubMed

At the histological examination of an increasing number of melanocytic tumors there is a need to use various immunohistochemical methods. Currently, we are supplied by several antibodies working well on formalin-fixed, paraffin-embedded samples. We have tested five antibodies (S-100, HMB-45, Melan-A, MITF, PNL-2) on 34 benign and 34 malignant melanocytic tumors. We examined the specificity and sensitivity in the junctional and dermal component separately, with special consideration to features disturbing the evaluation (regression, halo-like inflammation, etc.). We have concluded that the histological diagnosis of melanocytic tumors is based on the detailed examination of traditional HE slides and the immunohistochemical methods only confirm or weaken our opinion.